Parsortix system identifies key drug targets in cancer metastasis
Study demonstrates ability of the Parsortix system to isolate circulating tumour cells, targeting the metastatic spread of cancer
Read More
Tag: Lipid systems
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
